Helicobacter pylori infection has a detrimental impact on the efficacy of cancer immunotherapies | Gut

Subscribe
Log In More

Log in via Institution
Log in via OpenAthens
Log in via BSG

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
Basket
Search More

Search for this keyword

Advanced search

Article metrics

PDF +
Supplementary
Material

Helicobacter pylori

Original research

Helicobacter pylori infection has a detrimental impact on the efficacy of cancer immunotherapies

Online download statistics by month:

Online download statistics by month: July 2021 to March 2024

	Abstract	Full	Pdf
Jul 2021	2448	2409	928
Aug 2021	1830	1822	464
Sep 2021	534	535	171
Oct 2021	441	436	134
Nov 2021	440	417	137
Dec 2021	387	382	105
Jan 2022	337	333	121
Feb 2022	997	1002	354
Mar 2022	829	808	372
Apr 2022	604	555	250
May 2022	671	623	268
Jun 2022	497	432	199
Jul 2022	447	392	167
Aug 2022	390	343	175
Sep 2022	470	435	192
Oct 2022	336	282	145
Nov 2022	460	360	180
Dec 2022	320	277	142
Jan 2023	319	258	127
Feb 2023	319	248	140
Mar 2023	262	212	110
Apr 2023	232	186	139
May 2023	249	197	122
Jun 2023	229	181	101
Jul 2023	227	197	103
Aug 2023	159	132	69
Sep 2023	194	158	86
Oct 2023	404	348	129
Nov 2023	507	471	95
Dec 2023	403	341	110
Jan 2024	653	606	132
Feb 2024	381	358	92
Mar 2024	1053	1025	165
Total	18029	16761	6224